{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T10:10:06Z","timestamp":1715508606943},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.rmr.2012.10.629","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T12:37:06Z","timestamp":1371127026000},"page":"458-462","source":"Crossref","is-referenced-by-count":1,"title":["Pollinoses\u00a0: traitements m\u00e9dicamenteux"],"prefix":"10.1016","volume":"30","author":[{"given":"R.","family":"Harf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2012.10.629_bib0005","unstructured":"HAS. Avis CT-5767\u00a0du 28-11-2008."},{"key":"10.1016\/j.rmr.2012.10.629_bib0010","first-page":"517","article-title":"Pollinose et consommation de m\u00e9dications anti-allergiques\u00a0: ambroisie dans la r\u00e9gion Rh\u00f4ne-Alpes","volume":"18","author":"Harf","year":"2001","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2012.10.629_bib0015","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1365-2222.2003.01769.x","article-title":"Consensus group on new-generation antihistamines (CONGA): present status and recommendations","volume":"33","author":"Holgate","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2012.10.629_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1398-9995.1988.tb00433.x","article-title":"Effect of topical levocabastine on allergic and non-allergic perennial rhinitis. A double-blind study, levocabastine vs. placebo, followed by an open, prospective, single-blind study on beclomethasone","volume":"43","author":"Van de Heyning","year":"1988","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2012.10.629_bib0025","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances in H1-antihistamines","volume":"351","author":"Estelle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2012.10.629_bib0030","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinthera.2009.05.017","article-title":"A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis","volume":"5","author":"Bachert","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.rmr.2012.10.629_bib0035","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1365-2222.2009.03257.x","article-title":"Efficacy and safety of bilastine 20mg compared with cetirizine 10mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study","volume":"9","author":"Kuna","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2012.10.629_bib0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.amjmed.2003.10.030","article-title":"Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.rmr.2012.10.629_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1398-9995.2000.00108.x","article-title":"Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy","volume":"55","author":"Mygind","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2012.10.629_bib0050","first-page":"154","article-title":"Consumption of allergy medicines in 2000\u00a0and 2001: data from 12\u00a0Primary Medical Insurance Offices (CPAM) in the Rh\u00f4ne-Alpes region","volume":"35","author":"Christophe","year":"2003","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2012.10.629_bib0055","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1164\/ajrccm.164.supplement_1.2103023","article-title":"Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis","volume":"164","author":"Casale","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.10.629_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2222.2007.02894.x","article-title":"Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis","volume":"38","author":"Nagakura","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2012.10.629_bib0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2500\/aap.2007.28.2948","article-title":"Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis","volume":"28","author":"Blaiss","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmr.2012.10.629_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2009.11.020","article-title":"Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class","volume":"104","author":"Benninger","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2012.10.629_bib0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11882-010-0087-1","article-title":"Allergic conjunctivitis and the impact of allergic rhinitis","volume":"10","author":"Bielory","year":"2010","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.rmr.2012.10.629_bib0080","first-page":"628","article-title":"Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis","volume":"30","author":"Kalpaklioglu","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmr.2012.10.629_bib0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1081-1206(10)60804-6","article-title":"Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis","volume":"97","author":"Berger","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2012.10.629_bib0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2010.06.008","article-title":"Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device","volume":"105","author":"Hampel","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2012.10.629_bib0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)61225-2","article-title":"Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis","volume":"95","author":"Lange","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2012.10.629_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/108854198778557962","article-title":"The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis","volume":"19","author":"Kaiser","year":"1998","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmr.2012.10.629_bib0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000236003","article-title":"Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study","volume":"151","author":"Garavello","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.rmr.2012.10.629_bib0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/014556130508400713","article-title":"Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis","volume":"84","author":"Cordray","year":"2005","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.rmr.2012.10.629_bib0115","unstructured":"HAS. Avis CT-11269\u00a0du 05-10-2011."},{"key":"10.1016\/j.rmr.2012.10.629_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1185\/030079903125001785","article-title":"Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis","volume":"19","author":"James","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rmr.2012.10.629_bib0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/09286580701299411","article-title":"Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data","volume":"14","author":"Swamy","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.rmr.2012.10.629_bib0130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0149-2918(02)80080-7","article-title":"A comparaison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025\u00a0ophtalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge","volume":"24","author":"Crampton","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.rmr.2012.10.629_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1398-9995.2007.01549.x","article-title":"A survey of the burden of allergic rhinitis in Europe","volume":"s85","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2012.10.629_bib0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2012.10.629_bib0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4104\/pcrj.2010.00044","article-title":"Management of allergic and non-allergic rhinitis: a primary care summary of the British Society for Allergy & Clinical Immunology (BSACI) guideline","volume":"19","author":"Angier","year":"2010","journal-title":"Prim Care Respir J"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842512010042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842512010042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T09:45:29Z","timestamp":1715507129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842512010042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0761842512010042"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2012.10.629","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}